JNJ

Health care giant Johnson & Johnson (JNJ), hammered by numerous recalls that have kept some popular nonprescription medicines and other products off the market, posted a 12 percent profit decline and a 5.5 percent drop in revenue for the fourth quarter. The adjusted earnings from the maker of...

Led by the health insurance reform law, a flurry of drug and food recalls, key medical breakthroughs and plenty of layoffs and lawsuits, 2010 proved to be an exciting -- if not always positive -- year. Here's our rundown of the biggest health care stories.

Johnson & Johnson expanded its recall of Acuvue TruEye contact lenses fivefold back in October, but only announced the news in Japan, where most of the recalled lenses were sold.

Was Johnson & Johnson aware of problems with its Children's Tylenol months before the recall? The House Oversight Committee has invited an FDA commissioner and Johnson & Johnson chairman to a hearing next week to address this and other questions surrounding the massive recall of children's medicines earlier this year.

In a warning letter to J&J's DePuy Orthopaedics, the FDA says it is illegally marketing its TruMatch CT scanner and Corail Hip System. This is the latest in a series of problems at J&J, which include a big children's Tylenol recall.

Crisis management experts say the time is now for Toyota to do everything possible to reassure the public that it's fixing the problems -- and that consumers should not lose faith in the carmaker's reputation for quality.

The "Year of the Layoff" was supposed to be over now that the economy is improving and most large companies have fired as many people as they reasonably can. Productivity gains can only squeeze so much out of a shrinking work force. But American companies are aggressively chopping their...

For years, the price of Berkshire Hathaway (BRK.A)'s Class A and Class B common stock has been priced out of the range of what most retail investors can afford. A share of the less expensive of the two classes, the B, trades at about $3,300. Berkshire, run by Warren Buffett, announced on Tuesday...

It can sometimes be tough to get a straight answer about any potential problems with drugs from the companies that make them, if court records are any guide. AstraZeneca (AZN) told American doctors the company's antipsychotic drug Seroquel didn't cause diabetes, despite alerting Japanese physicians...

On Friday, shareholders for Merck & Co., Inc. (MRK) and Schering-Plough Corp. (SGP) set to vote on a $41 billion merger. In the meantime, the two companies appear to be doing some house cleaning. One of the first orders when such a deal goes through is to shake up top management, with many...